QA: Nascent Biotech Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001622057_2020_Nascent_Biotech_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Excluding company: variable exceeds outlier threshold pre-agg {'variable': 'Expenses', 'value': 3447321, 'size_variable': 'Assets', 'size_value': 3218, 'ratio': 1071.3, 'threshold': 20}

Graph

Absolute values for 0001622057, Nascent Biotech Inc

  xvar xval
0 AssetsCurrent 131,472
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 613,636
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 447,505
9 ResearchAndDevelopmentExpense 254,006
10 remainder_Expenses 667,437
11 remainder_Revenues 0
12 remainder_NetIncome 41.0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 131,472
1 Liabilities 613,636
2 Expenses 1,368,948
3 Revenues 0
4 StockholdersEquity -482,164
5 NetIncome -1,368,907
6 ComprehensiveNetIncome -1,368,907
7 BaseVar 1,057,048
8 EconomicCapitalRatiobeforeLimitedLiability -6.50
9 EconomicCapitalRatio 0.0482

Edgar->Model Mapping

Feature Distribution